Cite
Aberrant promoter methylation of p16(INK4a), RARB2 and SEMA3B in bronchial aspirates from patients with suspected lung cancer.
MLA
Grote, Hans J., et al. “Aberrant Promoter Methylation of P16(INK4a), RARB2 and SEMA3B in Bronchial Aspirates from Patients with Suspected Lung Cancer.” International Journal of Cancer, vol. 116, no. 5, Sept. 2005, pp. 720–25. EBSCOhost, https://doi.org/10.1002/ijc.21090.
APA
Grote, H. J., Schmiemann, V., Geddert, H., Rohr, U. P., Kappes, R., Gabbert, H. E., & Böcking, A. (2005). Aberrant promoter methylation of p16(INK4a), RARB2 and SEMA3B in bronchial aspirates from patients with suspected lung cancer. International Journal of Cancer, 116(5), 720–725. https://doi.org/10.1002/ijc.21090
Chicago
Grote, Hans J, Viola Schmiemann, Helene Geddert, Ulrich P Rohr, Rainer Kappes, Helmut E Gabbert, and Alfred Böcking. 2005. “Aberrant Promoter Methylation of P16(INK4a), RARB2 and SEMA3B in Bronchial Aspirates from Patients with Suspected Lung Cancer.” International Journal of Cancer 116 (5): 720–25. doi:10.1002/ijc.21090.